{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-03-18",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "status": "Terminated",
      "city": "Hauppauge",
      "state": "NY",
      "country": "United States",
      "classification": "Class III",
      "openfda": {
        "application_number": [
          "ANDA206674"
        ],
        "brand_name": [
          "BUPROPION HYDROCHLORIDE (SR)"
        ],
        "generic_name": [
          "BUPROPION HYDROCHLORIDE"
        ],
        "manufacturer_name": [
          "Cipla USA Inc.,"
        ],
        "product_ndc": [
          "69097-877",
          "69097-878",
          "69097-879"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "BUPROPION HYDROCHLORIDE"
        ],
        "rxcui": [
          "993503",
          "993518",
          "993536"
        ],
        "spl_id": [
          "a9b85841-5a69-4df1-a22d-3d4cf174e9a6"
        ],
        "spl_set_id": [
          "9d2c209b-248e-4e26-9cde-fe0abe4428c1"
        ],
        "package_ndc": [
          "69097-877-02",
          "69097-877-03",
          "69097-877-07",
          "69097-877-12",
          "69097-878-02",
          "69097-878-03",
          "69097-878-07",
          "69097-878-12",
          "69097-879-02",
          "69097-879-03",
          "69097-879-07",
          "69097-879-12"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0369097879037",
          "0369097878030",
          "0369097877033"
        ],
        "unii": [
          "ZG7E5POY8O"
        ]
      },
      "product_type": "Drugs",
      "event_id": "79446",
      "recalling_firm": "InvaGen Pharmaceuticals, Inc.",
      "address_1": "7 Oser Ave",
      "address_2": "N/A",
      "postal_code": "11788-3811",
      "voluntary_mandated": "Voluntary: Firm initiated",
      "initial_firm_notification": "Letter",
      "distribution_pattern": "Nationwide",
      "recall_number": "D-0618-2018",
      "product_description": "buPROPion HCl Extended-Release Tablets,   USP (SR), 100 mg, 60 count bottles, Rx Only, Manufactured for: Cipla USA Inc. 1560 Sawgrass Corporate Parkway Suite 130 Sunrise, FL 33323, Manufactured by: InvaGen Pharmaceuticals, Inc. (a subsidiary of Cipla Ltd.) Hauppauge, NY 11788 --- NDC 69097-877-03",
      "product_quantity": "N/A",
      "reason_for_recall": "Failed Dissolution Specifications; during stability testing",
      "recall_initiation_date": "20180315",
      "center_classification_date": "20180404",
      "termination_date": "20210915",
      "report_date": "20180411",
      "code_info": "Lot# I1606579 and Lot# I1606580 Exp: 05/2018; Lot# I1612114 and Lot# I1612115 Exp: 11/2018"
    }
  ]
}